Annual Current Liabilities
$123.90 M
+$1.34 M+1.10%
December 31, 2024
Summary
- As of March 6, 2025, GDRX annual total current liabilities is $123.90 million, with the most recent change of +$1.34 million (+1.10%) on December 31, 2024.
- During the last 3 years, GDRX annual current liabilities has risen by +$42.79 million (+52.75%).
- GDRX annual current liabilities is now at all-time high.
Performance
GDRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$123.90 M
+$9.54 M+8.34%
December 31, 2024
Summary
- As of March 6, 2025, GDRX quarterly total current liabilities is $123.90 million, with the most recent change of +$9.54 million (+8.34%) on December 31, 2024.
- Over the past year, GDRX quarterly current liabilities has increased by +$9.54 million (+8.34%).
- GDRX quarterly current liabilities is now at all-time high.
Performance
GDRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
GDRX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.1% | +8.3% |
| 3 y3 years | +52.8% | +5.2% |
| 5 y5 years | +271.3% | +5.2% |
GDRX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.4% | at high | +108.7% |
| 5 y | 5-year | at high | +271.3% | at high | +271.3% |
| alltime | all time | at high | +645.5% | at high | +271.3% |
GoodRx Holdings Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $123.90 M(+1.1%) | $123.90 M(+8.3%) |
| Sep 2024 | - | $114.36 M(+11.6%) |
| Jun 2024 | - | $102.47 M(-12.1%) |
| Mar 2024 | - | $116.52 M(-4.9%) |
| Dec 2023 | $122.56 M(+60.6%) | $122.56 M(+4.0%) |
| Sep 2023 | - | $117.82 M(+42.7%) |
| Jun 2023 | - | $82.55 M(+19.7%) |
| Mar 2023 | - | $68.98 M(-9.6%) |
| Dec 2022 | $76.32 M | $76.32 M(-10.2%) |
| Sep 2022 | - | $84.97 M(+6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $79.62 M(+34.1%) |
| Mar 2022 | - | $59.36 M(-26.8%) |
| Dec 2021 | $81.11 M(+36.2%) | $81.11 M(+11.6%) |
| Sep 2021 | - | $72.68 M(+11.0%) |
| Jun 2021 | - | $65.49 M(+3.9%) |
| Mar 2021 | - | $63.05 M(+5.9%) |
| Dec 2020 | $59.55 M(+78.4%) | $59.55 M(-1.0%) |
| Sep 2020 | - | $60.16 M(+0.2%) |
| Jun 2020 | - | $60.03 M(+79.9%) |
| Dec 2019 | $33.37 M(+100.8%) | $33.37 M |
| Dec 2018 | $16.62 M | - |
FAQ
- What is GoodRx Holdings annual total current liabilities?
- What is the all time high annual current liabilities for GoodRx Holdings?
- What is GoodRx Holdings annual current liabilities year-on-year change?
- What is GoodRx Holdings quarterly total current liabilities?
- What is the all time high quarterly current liabilities for GoodRx Holdings?
- What is GoodRx Holdings quarterly current liabilities year-on-year change?
What is GoodRx Holdings annual total current liabilities?
The current annual current liabilities of GDRX is $123.90 M
What is the all time high annual current liabilities for GoodRx Holdings?
GoodRx Holdings all-time high annual total current liabilities is $123.90 M
What is GoodRx Holdings annual current liabilities year-on-year change?
Over the past year, GDRX annual total current liabilities has changed by +$1.34 M (+1.10%)
What is GoodRx Holdings quarterly total current liabilities?
The current quarterly current liabilities of GDRX is $123.90 M
What is the all time high quarterly current liabilities for GoodRx Holdings?
GoodRx Holdings all-time high quarterly total current liabilities is $123.90 M
What is GoodRx Holdings quarterly current liabilities year-on-year change?
Over the past year, GDRX quarterly total current liabilities has changed by +$9.54 M (+8.34%)